drugset / Trial / NCT04882631
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NaSingle-groupOpen-labelOther
Summary
This is an open-label, single-arm, randomized, evaluator-blinded repeat insult patch testing (RIPT) study wherein test product is applied under an occlusive dressing to the upper back or arm continuously and repeatedly to the same site for a period of 21 days.
Timeline
- Start
- 2021-04-12
- Primary completion
- 2021-05-03
- Completion
- 2021-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBI-100 | Unknown | 560 ug | Topical |
| Background | Sodium laurel sulfate | Unknown | 0.25 % | Topical |
Indications
No indication recorded.